Ovarian Cancer Treatment in Raipur

Ovarian cancer develops when cells in one or both ovaries grow and divide abnormally, forming a tumour capable of spreading beyond the ovary itself. It ranks among the more challenging gynaecological cancers to catch early, largely because its initial symptoms like bloating, mild pelvic discomfort and changes in appetite mimic far more common and far less serious conditions. Roughly one in seventy women will develop some form of ovarian cancer during her lifetime and outcomes improve substantially when the disease is caught before it spreads beyond the pelvis. Genetics plays a meaningful role in a subset of patients, particularly those carrying BRCA1 or BRCA2 mutations, while for many others no single clear cause is ever identified. This article explains the recognised types of ovarian cancer, how the disease presents, the diagnostic pathway used to confirm it, and the treatment options available at each stage.

What Is Ovarian Cancer?

The ovaries are a pair of small, almond-shaped organs on either side of the uterus, responsible for producing eggs and the hormones oestrogen and progesterone. Ovarian cancer begins when cells within the ovary or in some cases the fallopian tube or the lining of the pelvis, acquire genetic changes that let them grow uncontrolled. Left unchecked, these abnormal cells can invade nearby tissue and later spread through the abdominal cavity, the lymphatic system or the bloodstream. Because the ovaries sit deep within the pelvis, a tumour can grow to a considerable size before it presses on nearby organs enough to cause noticeable symptoms, which is part of why the condition is frequently diagnosed at a more advanced stage than many other cancers.

Types of Ovarian Cancer

Ovarian tumours are classified according to the cell type from which they originate:

• Epithelial ovarian cancer: Arises from the thin layer of tissue covering the ovary, accounts for the majority of all cases and is the form most people mean when discussing this disease.
• Germ cell tumours: Develop from the cells that would otherwise form eggs, occur more often in younger women and generally respond well to treatment.
• Stromal tumours: Arise from the hormone-producing supportive tissue within the ovary and can sometimes cause hormonal symptoms including abnormal bleeding, before they are otherwise noticed.
• Primary peritoneal cancer: It behaves almost identically to epithelial ovarian cancer but originates in the lining of the abdominal cavity rather than the ovary itself.
• Borderline tumours: A distinct category, they show some abnormal features under the microscope but tend not to spread aggressively and carry a considerably better outlook.

Symptoms of Ovarian Cancer

Symptoms are frequently vague in the early stages, which is precisely why persistence and pattern matter more than any single symptom alone:

• Persistent bloating that does not resolve within a few weeks, rather than the temporary bloating linked to diet or the menstrual cycle.
• Pelvic or abdominal pain that lingers rather than coming and going with a clear trigger.
• Because a growing tumour can press on the stomach, feeling full quickly after eating even small amounts is a commonly reported early sign.
• Urinary urgency or increased frequency, occurring without a urinary tract infection to explain it.
• Irregular vaginal bleeding particluarly after menopause.
• Unexplained changes in bowel habits including new constipation or diarrhoea.
• Fatigue that persists despite adequate rest and does not track with any other obvious cause.
• Unintended weight loss or less commonly weight gain from fluid build-up in the abdomen.
• Back pain, particularly low back pain that develops alongside the other symptoms listed here.

Causes of Ovarian Cancer

A single definitive cause is rarely identified, though several biological pathways are well documented:

• Inherited mutations in the BRCA1 or BRCA2 genes substantially raise lifetime risk and account for a meaningful proportion of cases.
• Lynch syndrome, an inherited condition affecting DNA repair, raises the risk of ovarian cancer alongside several other cancer types.
• Because ovulation involves repeated minor injury and repair to the ovarian surface, a higher lifetime number of ovulatory cycles is linked to increased risk.
• Endometriosis, where tissue similar to the uterine lining grows outside the uterus, is associated with a modestly increased risk of certain ovarian cancer subtypes.
• Long-term hormone replacement therapy, particularly oestrogen-only regimens used for many years, has been linked to a small increase in risk.
• Age-related accumulation of cellular changes over decades explains why risk climbs steadily after menopause.

Risk of Ovarian Cancer

Certain personal and family factors meaningfully raise the likelihood of developing this disease:

• Age above 50, since the majority of cases are diagnosed after menopause.
• A family history of ovarian, breast or colorectal cancer, particularly across multiple close relatives.
• Never having been pregnant, since pregnancy appears to offer some protective effect through reduced lifetime ovulation.
• Starting periods early or reaching menopause late, both of which extend the total number of ovulatory cycles over a lifetime.
• Obesity, which is independently associated with a modestly higher risk across several studies.
• A personal history of breast cancer, particularly when linked to a known genetic mutation.

Complications of Ovarian Cancer

As the disease advances, it can produce complications extending well beyond the ovaries themselves. They are:

• Ascites, a build-up of fluid within the abdominal cavity, commonly develops as the disease progresses and can cause significant discomfort and breathlessness.
• Bowel obstruction can occur when a tumour or its spread physically blocks part of the intestine, sometimes requiring surgical intervention.
• Pleural effusion, fluid accumulating around the lungs, can develop when the cancer spreads to the chest cavity.
• Malnutrition and significant weight loss frequently accompany advanced disease, partly from reduced appetite and partly from the cancer's own metabolic effects.
• Because chemotherapy and surgery both carry their own risks & treatment related complications (including infection and blood clots) you may require careful monitoring throughout care.

Diagnosis of Ovarian Cancer

Diagnosis typically combines a physical examination with imaging, blood tests and tissue confirmation:

• Clinical examination: A pelvic examination allows a doctor to feel for any abnormal mass or swelling in the ovaries or surrounding pelvic structures.
• Ultrasound: Transvaginal ultrasound provides a detailed initial view of the ovaries and is usually the first imaging test ordered.
• Blood tests: CA-125 blood testing measures a protein often elevated in ovarian cancer (though it can also rise in several benign conditions limiting its use as a standalone test).
• Imaging: CT or MRI imaging maps the extent of any tumour and checks for spread to nearby organs or lymph nodes.
• Biopsy: Because imaging alone cannot confirm cancer definitively, a tissue biopsy provides the conclusive diagnosis.
• Genetic testing: Testing for BRCA1, BRCA2, and related mutations is now routinely offered, since results directly influence treatment choices and family screening.

Treatment for Ovarian Cancer

Treatment is tailored to the specific type and stage of the cancer, and most patients receive a combination of approaches:

• Surgery: Often involves removal of the ovaries, fallopian tubes and uterus, along with as much visible tumour as possible and forms the backbone of treatment for most patients.
• Chemotherapy: Platinum-based combination regimens are used both after surgery to eliminate remaining cancer cells and, in some cases, before surgery to shrink a large tumour first.
• Targeted therapy: PARP inhibitors have transformed outcomes most commonly for patients with BRCA mutations, offering a maintenance treatment option after initial chemotherapy.
• Radiation therapy: Radiotherapy is used less frequently in ovarian cancer than in many other cancer types (though it can control symptoms in some situations).
• Because ovarian cancer can recur even after successful initial treatment, maintenance therapy and regular follow-up monitoring form an important part of long-term care.

When Should You See a Doctor?

Certain patterns of symptoms warrant prompt evaluation and for which a wait-and-see approach may be risky. They are:

• Persistent bloating or abdominal swelling lasting more than two to three weeks
• Pelvic or abdominal pain that does not resolve or keeps recurring
• Feeling full quickly or having reduced appetite without an obvious cause
• New urinary urgency or frequency without signs of a urinary tract infection.
• If you have a strong family history of ovarian, breast or colorectal cancer, particularly alongside any new symptoms listed above
• Postmenopausal bleeding of any kind.

Why Choose Ramkrishna CARE Hospital for Ovarian Cancer Treatment in Raipur?

Ramkrishna CARE Hospital, Raipur brings together gynaecological oncologists, surgical specialists and a dedicated cancer care team experienced in managing the full range of ovarian cancer types and stages. Patients benefit from access to transvaginal ultrasound, CT and MRI imaging, and pathology services under a single roof, allowing diagnosis and staging to proceed without the delays that come from travelling between multiple centres. A multidisciplinary tumour board, involving surgeons, medical oncologists, radiologists and pathologists, reviews complex cases together to agree on the most appropriate treatment plan for each patient.

Beyond diagnosis and surgery, the hospital's oncology unit provides chemotherapy in a structured day-care setting, genetic counselling for patients with a suspected inherited risk and coordinated follow-up care for long-term monitoring after treatment. This continuity from the first consultation through surgery, chemotherapy and survivorship follow-up, allows patients and their families in Raipur and the surrounding region to receive comprehensive ovarian cancer care without needing to seek treatment elsewhere.

Conclusion

Ovarian cancer remains difficult to identify early because its initial symptoms overlap closely with other common, benign conditions, yet awareness of symptoms like persistent bloating, pelvic pain, irregular vaginal bleeding, and fatigue occurring together can prompt earlier evaluation and better outcomes. A combination of surgery, chemotherapy, and ongoing monitoring now offers real prospects for long-term control even in more advanced cases. Anyone experiencing persistent, unexplained symptoms or carrying a significant family history should consult a doctor rather than waiting for symptoms to worsen.